Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Nextleaf Solutions secures C$3M in convertible note financing

% of readers think this story is Fact. Add your two cents.


Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) has closed a private placing with an institutional investor, raising C$3 million gross, which it says will be used to enhance the company’s automation and additional manufacturing capabilities in 2021. 

The financing is in the form of a senior secured convertible note of the company in the principal amount of C$3.3 million and a warrant to purchase up to 6.875 million Nextleaf shares. 

READ: Nextleaf Solutions supplies its Rapid Emulsion Technology to cannabis-infused beverage manufacturer BevCanna Enterprises

“Since commercializing our automated proprietary closed-loop refinery in mid-2020, Nextleaf has been highly focused on building our Commercial Partners Program and expanding our intellectual property portfolio,” Charles Ackerman, the chief financial officer of cannabis processing group Nextleaf, told investors in a statement.

“We are pleased our focused and measured approach continues to attract significant investment interest, despite challenges and variability in the market.”

The company said the net proceeds from the offering will be used to “enhance efficiencies through automation and additional manufacturing capabilities in 2021 and for general corporate and working capital purposes”.

The note will mature 18 months from issue and bears guaranteed interest at a rate of 5% per year.

The principal amount is convertible, if the investor chooses, into Nextleaf shares at C$0.288 per share at any time prior to the close of business on the last day immediately preceding the maturity date, subject to certain circumstances.

The warrant is exercisable into shares at C$0.288 each for 36 months from the date of issue.

Early in March this year, the company announced an initial order for its Rapid Emulsion Technology by OILS THC and CBD to cannabis-infused beverage manufacturer BevCanna Enterprises Inc (CSE:BEV) (QTCQB:BVNNF) (FRA:7BC).

With this initial order, Nextleaf said its Rapid concentrate becomes one of BevCanna’s preferred ingredients, available for use in both their brands and their partner brands. Rapid is Nextleaf’s patent-pending delivery technology.

BevCanna develops and manufactures a range of cannabis-infused beverages for both in-house brands and white-label clients, and is the exclusive Canadian licensee for the award-winning, No.1 selling brand in the US — Keef Brands.

Contact the author at [email protected]

Story by ProactiveInvestors


Source: http://www.proactiveinvestors.com/companies/news/945609/nextleaf-solutions-secures-c3m-in-convertible-note-financing-945609.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.